Skip to main content
. Author manuscript; available in PMC: 2023 Apr 14.
Published in final edited form as: Neurocrit Care. 2022 Sep 27;38(2):345–355. doi: 10.1007/s12028-022-01599-9

Table 4.

Unweighted Fine-Gray Subdistribution Hazard Model for Cumulative Incidence of Early PTS

Early PTS Death
sHR (95% CI) P-value sHR (95% CI) P-value
Age (1-year increase) 1.04 (1.02, 1.07) <0.01 1.02 (1, 1.05) 0.09
AIS head > 31 3.65 (1.47, 9.07) <0.01 2.01 (1.02, 3.97) 0.04
Pre-hospital GCS >102 0.42 (0.22, 0.81) <0.01 0.2 (0.1, 0.37) <0.01
Operative intervention 3.89 (2.15, 7.03) <0.01 0.64 (0.33, 1.23) 0.18
Daily dose <=1000 mg/day3 0.53 (0.22, 1.28) 0.16 0.89 (0.36, 2.23) 0.8
Daily dose >=2000 mg/day3 1.22 (0.57, 2.58) 0.61 1.22 (0.57, 2.58) 0.48
Cortical contusion 1.31 (0.64, 2.68) 0.46 0.85 (0.42, 1.72) 0.66
Intracranial hemorrhage 0.61 (0.07, 5.42) 0.66 0.39 (0.15, 0.99) 0.05
Penetrating head wound Not included4 2.89 (1.17, 7.16) 0.02
Depressed skull fracture 0.46 (0.05, 4.14) 0.49 Not included4
CrCl (1-unit increase) 1 (0.99, 1.01) 0.64 0.99 (0.98, 1) 0.16
1

AIS head ≤3 used as reference value

2

Pre-hospital GCS ≤10 used as reference value

3

Daily levetiracetam dose of 1500 mg/day used as reference value

4

Variable was not included in the model because of the complete separation of patients.

sHR: Subdistribution hazard ratio. AIS: Abbreviated Injury Scale. GCS: Glasgow Coma Scale. CrCl: Creatinine clearance.